Olof Heimbürger

Q: What Schools Are Affiliated With Olof Heimbürger

Olof Heimbürger is affiliated with the following schools: Stockholm University, University of Oviedo, Uppsala University, Lund University, Karolinska Institute

Olof Heimbürger's AcademicInfluence.com Rankings

Olof Heimbürger

Chemistry

#3747

World Rank

#4787

Historical Rank

Analytical Chemistry

#153

World Rank

#160

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Olof Heimbürger's Degrees

PhD Chemistry Stockholm University

Why Is Olof Heimbürger Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Olof Heimbürger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. (1999) (1706)
IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. (2005) (847)
Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). (2000) (820)
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? (2008) (553)
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. (2006) (500)
Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. (2002) (473)
Associations between circulating inflammatory markers and residual renal function in CRF patients. (2003) (408)
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. (2002) (396)
Impact of inflammation on epigenetic DNA methylation – a novel risk factor for cardiovascular disease? (2007) (379)
Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. (2014) (350)
Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. (1990) (343)
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. (2005) (343)
Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. (2003) (338)
Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. (2007) (276)
Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. (2001) (262)
Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. (2000) (262)
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. (2008) (245)
Nutritional status in dialysis patients: a European consensus. (2002) (244)
Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. (2006) (232)
Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. (2007) (231)
Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. (2002) (227)
Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease (2016) (225)
Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? (2002) (224)
Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. (1997) (218)
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? (2002) (216)
J-shaped mortality relationship for uric acid in CKD. (2006) (216)
Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. (1998) (210)
Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. (2008) (209)
A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. (2002) (208)
Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. (2000) (201)
Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity. (2002) (197)
Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. (2000) (194)
Truncal fat mass as a contributor to inflammation in end-stage renal disease. (2004) (193)
Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. (2005) (190)
Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. (2004) (189)
Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease. (2000) (181)
A quantitative description of solute and fluid transport during peritoneal dialysis. (1992) (177)
Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease (2007) (175)
Low serum testosterone increases mortality risk among male dialysis patients. (2009) (170)
Telomere attrition is associated with inflammation, low fetuin‐A levels and high mortality in prevalent haemodialysis patients (2008) (170)
Calculation of the Protein Equivalent of Total Nitrogen Appearance from Urea Appearance. Which Formulas Should be Used? (1998) (168)
Low leptin gene expression and hyperleptinemia in chronic renal failure. (1998) (168)
Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. (2007) (166)
Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis. (1992) (158)
Serum albumin as predictor of nutritional status in patients with ESRD. (2012) (155)
When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study. (2011) (153)
Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. (2011) (148)
Physical activity and energy expenditure in haemodialysis patients: an international survey. (2012) (146)
Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. (2001) (145)
Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min). (2015) (140)
Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. (2003) (139)
Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. (2003) (138)
A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. (2003) (133)
Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD. (2016) (133)
Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. (2010) (127)
Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. (2007) (127)
Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. (2008) (124)
Adipose tissue and its relation to inflammation: the role of adipokines. (2005) (121)
Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. (2004) (121)
Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. (2005) (118)
Do ACE‐inhibitors suppress tumour necrosis factor‐α production in advanced chronic renal failure? (1999) (116)
Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients. (2009) (115)
Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. (2009) (115)
European best practice guidelines for peritoneal dialysis. 3 Peritoneal access. (2005) (110)
Influence of Peritoneal Transport Rate, Inflammation, and Fluid Removal on Nutritional Status and Clinical Outcome in Prevalent Peritoneal Dialysis Patients (2003) (109)
Malnutrition, Inflammation, and Atherosclerosis in Peritoneal Dialysis Patients (2001) (109)
Systemic and Intraperitoneal Interleukin-6 System during the First Year of Peritoneal Dialysis (2006) (108)
Chronic Inflammation in Peritoneal Dialysis: The Search for the Holy Grail? (2004) (105)
Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. (1997) (103)
Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board. (2010) (101)
Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. (2012) (97)
Wasting, but not malnutrition, predicts cardiovascular mortality in end-stage renal disease. (2004) (97)
Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. (2005) (93)
A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. (1998) (87)
A quantitative analysis of sodium transport and removal during peritoneal dialysis. (1997) (86)
The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease (2018) (86)
Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD. (2005) (84)
Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD. (1994) (83)
Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group. (2010) (83)
Soluble leptin receptors and serum leptin in end‐stage renal disease: relationship with inflammation and body composition (2002) (82)
Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. (2009) (82)
Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients. (2010) (81)
Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease. (2012) (80)
Simple models for description of small-solute transport in peritoneal dialysis. (1991) (78)
Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. (2000) (77)
European best practice guidelines for peritoneal dialysis. 7 Adequacy of peritoneal dialysis. (2005) (77)
Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. (1998) (76)
Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients. (2011) (75)
The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. (2006) (74)
Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship? (2010) (73)
Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. (2006) (73)
Alterations in Water and Solute Transport with Time on Peritoneal Dialysis (1999) (73)
European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). (2008) (70)
Peritonitis in Continuous Ambulatory Peritoneal Dialysis (CAPD): Diagnostic Findings, Therapeutic Outcome and Complications (1989) (70)
High serum hyaluronan indicates poor survival in renal replacement therapy. (1999) (69)
The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. (2008) (67)
Effect of increased dialysate fill volume on peritoneal fluid and solute transport. (1997) (66)
Lipoprotein(a) in nephrotic syndrome. (1993) (66)
Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. (2012) (65)
Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy. (2004) (65)
Soluble adhesion molecules in end-stage renal disease: a predictor of outcome. (2006) (65)
Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. (2004) (64)
Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality (2003) (64)
High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome study. (2010) (64)
Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange. (2008) (64)
Does a High Peritoneal Transport Rate Reflect a State of Chronic Inflammation? (1999) (63)
Experimental models in peritoneal dialysis: a European experience. (1998) (63)
Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. (1996) (60)
Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients. (2011) (60)
Does statins promote vascular calcification in chronic kidney disease? (2017) (59)
Lyphatic absorption in CAPD patients with loss of ultrafiltration capacity. (1995) (58)
Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy. (2002) (58)
Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence. (2015) (57)
Editorial: Poor Outcomes for Fast Transporters on PD: The Rise and Fall of a Clinical Concern (2007) (56)
Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients (2017) (56)
Enhanced RAGE-mediated NFκB stimulation in inflamed hemodialysis patients (2005) (56)
Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation (2009) (56)
Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease. (2011) (55)
Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences. (2004) (55)
Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. (2003) (55)
Low serum fetuin‐A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients (2008) (55)
Diffusive mass transport coefficients are not constant during a single exchange in continuous ambulatory peritoneal dialysis. (1996) (54)
Osmotic Conductance of the Peritoneum in Capd Patients with Permanent Loss of Ultrafiltration Capacity (1996) (53)
Clinical importance of an elevated circulating chemerin level in incident dialysis patients. (2010) (52)
Clinical determinants of reduced physical activity in hemodialysis and peritoneal dialysis patients (2015) (51)
Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels. (2010) (51)
Is Serum Albumin An Index of Nutritional Status in Continuous Ambulatory Peritoneal Dialysis Patients? (1994) (50)
Increased expression of pro‐inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients (2011) (50)
Essential polyunsaturated fatty acids, inflammation and mortality in dialysis patients. (2012) (50)
POOR NUTRITIONAL STATUS AND INFLAMMATION: Novel Approaches in an Integrated Therapy of Inflammatory‐Associated Wasting in End‐Stage Renal Disease (2004) (49)
A comparative analysis of mass transport models in peritoneal dialysis. (1991) (48)
Adipose tissue and inflammation in chronic kidney disease. (2006) (48)
Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. (2005) (48)
Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients. (2015) (48)
European best practice guidelines for peritoneal dialysis. 8 Nutrition in peritoneal dialysis. (2005) (47)
Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure? (1999) (47)
Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy. (2004) (46)
Diffusive and convective solute transport in peritoneal dialysis with glucose as an osmotic agent. (1995) (46)
Methods for Estimation of Peritoneal Dialysate Volume and Reabsorption Rate Using Macromolecular Markers (1994) (46)
Hyaluronan decreases peritoneal fluid absorption in peritoneal dialysis. (1997) (46)
Simple Models for Fluid Transport during Peritoneal Dialysis (1996) (45)
Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume. (1998) (45)
Diverticular disease of the colon: a risk factor for peritonitis in continuous peritoneal dialysis. (1990) (44)
Determination of High and Low Molecular Weight Molecules of Icodextrin in Plasma and Dialysate, Using Gel Filtration Chromatography, in Peritoneal Dialysis Patients (2005) (43)
Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease? (2006) (43)
Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease. (2004) (43)
The Role of the TGF/Smad Signaling Pathway in Peritoneal Fibrosis Induced by Peritoneal Dialysis Solutions (2008) (42)
Oxidative DNA Damage and Mortality in Hemodialysis and Peritoneal Dialysis Patients (2015) (42)
Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients. (2013) (41)
Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients. (2006) (41)
Simple Membrane Models for Peritoneal Dialysis Evaluation of Diffusive and Convective Solute Transport (1992) (41)
Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients. (2016) (40)
Peritoneal Transport during Dialysis with Amino Acid-Based Solutions (1993) (39)
What is the Link between Poor Ultrafiltration and Increased Mortality in Anuric Patients on Automated Peritoneal Dialysis? Analysis of Data from Eapos (2006) (39)
Six Years’ Experience of CAPD at One Centre: A Survey of Major Findings (1988) (39)
Dialysis modality and nutritional status are associated with variability of inflammatory markers. (2016) (38)
Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism. (2006) (38)
Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival. (2011) (37)
Oral health and pro-inflammatory status in end-stage renal disease patients. (2007) (37)
Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. (2009) (37)
Subclinical versus overt obesity in dialysis patients: more than meets the eye. (2013) (37)
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease (2018) (37)
European best practice guidelines for peritoneal dialysis. 2 The initiation of dialysis. (2005) (37)
Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis? (2013) (37)
Hyaluronan decreases peritoneal fluid absorption: effect of molecular weight and concentration of hyaluronan. (1999) (37)
Paradoxes in Peritoneal Transport of Small Solutes (1996) (36)
Residual renal function, peritoneal transport characteristics and dialysis adequacy in peritoneal dialysis. (1996) (36)
Educating end-stage renal disease patients on dialysis modality selection (2010) (34)
The Use of Estimated Glomerular Filtration Rate for Dose Adjustment of Medications in the Elderly (2014) (34)
Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis. (2001) (34)
Peritoneal ultrafiltration and fluid reabsorption during peritoneal dialysis. (1989) (32)
Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients. (2005) (32)
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients (2019) (32)
Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy. (2006) (32)
Peritonitis during Continuous Ambulatory Peritoneal Dialysis (CAPD): Risk Factors, Clinical Severity, and Pathogenetic Aspects (1988) (32)
Determinants and survival implications of low bone mineral density in end-stage renal disease patients. (2013) (32)
Does the ob gene product leptin stimulate erythropoiesis in patients with chronic renal failure? (1998) (31)
IGF-1 and survival in ESRD. (2014) (31)
Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease (2016) (30)
Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease. (2002) (30)
Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution. (2000) (30)
Maintenance of optimal nutrition in CAPD. (1994) (29)
Peroxisome proliferator-activated receptor γ polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy (2005) (29)
Daily exposure to dialysis fluid results in changes in peritoneal transport. (1997) (29)
Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly (2015) (29)
Adequacy Targets Can be Met in Anuric Patients by Automated Peritoneal Dialysis: Baseline Data from Eapos (2001) (29)
Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation (2012) (29)
Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients. (2009) (29)
Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study (2019) (28)
Effect of alternative osmotic agents on peritoneal transport. (1993) (28)
Bone Mineral Density in End-Stage Renal Disease Patients: Association with Wasting, Cardiovascular Disease and Mortality (2008) (28)
Is Fetuin-A/α2-Heremans-Schmid Glycoprotein Associated with the Metabolic Syndrome in Patients with Chronic Kidney Disease? (2008) (28)
Influence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patients. (1998) (28)
Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis (2017) (27)
Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis. (2009) (27)
Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation? (2006) (27)
Evaluation of an experimental rat model for peritoneal dialysis: fluid and solute transport characteristics. (1994) (26)
Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease (2018) (26)
Interleukin-1 Gene Cluster Polymorphisms Are Associated with Nutritional Status and Inflammation in Patients with End-Stage Renal Disease (2005) (26)
N-Terminal Pro-Brain Natriuretic Peptide Independently Predicts Protein Energy Wasting and Is Associated with All-Cause Mortality in Prevalent HD Patients (2008) (26)
Icodextrin Metabolism and Alpha-Amylase Activity in Nonuremic Rats Undergoing Chronic Peritoneal Dialysis (2007) (25)
Peritoneal Fluid and Solute Transport with Different Polyglucose Formulations (1998) (25)
Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease (2018) (25)
What are the causes of protein-energy malnutrition in chronic renal insufficiency? (2002) (25)
Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration. (1999) (25)
Temporal discrepancies in the association between the apoB/apoA‐I ratio and mortality in incident dialysis patients (2009) (24)
Bidirectional Solute Transport in Peritoneal Dialysis (1994) (24)
European best practice guidelines for peritoneal dialysis. 6 Automated peritoneal dialysis. (2005) (24)
Plasma fatty acids in chronic kidney disease: nervonic acid predicts mortality. (2012) (24)
Determination of α-Amylase Activity in Serum and Dialysate from Patients Using Icodextrin-Based Peritoneal Dialysis Fluid (2003) (24)
Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study (2019) (23)
Uraemic symptom burden and clinical condition in women and men of ≥65 years of age with advanced chronic kidney disease: results from the EQUAL study. (2018) (23)
Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients. (1997) (22)
The Effect of Dialysate Acidity on Peritoneal Solute Transport in the Rat (1995) (22)
Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients (2015) (21)
Fluid and Solute Transport in CAPD Patients before and after Permanent Loss of Ultrafiltration Capacity (2005) (21)
Self-rated appetite as a predictor of mortality in patients with stage 5 chronic kidney disease. (2013) (21)
Albumin and Amino Acid Levels as Markers of Adequacy in Continuous Ambulatory Peritoneal Dialysis (1994) (21)
Variations in C-reactive protein during a single haemodialysis session do not associate with mortality. (2010) (20)
Being an inflamed peritoneal dialysis patient - a Dante's journey. (2006) (20)
Subclinical Atherosclerosis, Endothelial Function, and Serum Inflammatory Markers in Chronic Kidney Disease Stages 3 to 4 (2014) (20)
Adipokines in Chronic Kidney Disease — Fat Tissue Gives Nephrologists a Message (2005) (19)
Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease. (2018) (19)
Buffer transport in peritoneal dialysis. (2003) (19)
Associations between the CYBA 242C/T and the MPO –463G/A Polymorphisms, Oxidative Stress and Cardiovascular Disease in Chronic Kidney Disease Patients (2007) (19)
Retraining for prevention of peritonitis in peritoneal dialysis patients: A randomized controlled trial (2020) (19)
Clinical determinants and mortality predictability of stearoyl‐CoA desaturase‐1 activity indices in dialysis patients (2013) (18)
Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: A cohort study. (2019) (18)
Physiological Saline is not a Biocompatible Peritoneal Dialysis Solution (1999) (18)
Time dependence of solute removal during a single exchange. (1997) (17)
Beyond the membrane--the role of new PD solutions in enhancing global biocompatibility. (2003) (17)
Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease (2011) (17)
Discriminative Impact of Ultrafiltration on Peritoneal Protein Transport (2000) (17)
Serum Retinol-Binding Protein Concentration and Its Association with Components of the Uremic Metabolic Syndrome in Nondiabetic Patients with Chronic Kidney Disease Stage 5 (2008) (17)
Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease (2010) (16)
Place of genotyping and phenotyping in understanding and potentially modifying outcomes in peritoneal dialysis patients. (2006) (16)
Nutritional Problems in Peritoneal Dialysis: An Overview (1999) (15)
The Negative Results of the Ademex Study may be Positive for Peritoneal Dialysis. Time for a Paradigm Shift in the Focus of Peritoneal Dialysis Adequacy? (2002) (15)
Determinants of Fibroblast Growth Factor-23 and Parathyroid Hormone Variability in Dialysis Patients (2013) (15)
The future of European Nephrology ‘Guidelines’—a declaration of intent by European Renal Best Practice (ERBP) (2009) (15)
European best practice guidelines for peritoneal dialysis. 5 Peritoneal dialysis solutions. (2005) (15)
Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats. (2002) (14)
Suboptimal dialysis initiation is associated with comorbidities and uraemia progression rate but not with estimated glomerular filtration rate (2020) (14)
Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease. (2019) (14)
Obesity on PD patients: causes and management. (2003) (14)
European best practice guidelines for peritoneal dialysis. 9 PD and transplantation. (2005) (14)
European best practice guidelines for peritoneal dialysis. 4 Continuous ambulatory peritoneal dialysis delivery systems. (2005) (13)
Recovery of Renal Function after One-Year of Dialysis Treatment: Case Report and Registry Data (2010) (13)
Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients (2018) (13)
Adipokine signaling in the peritoneal dialysis patient. (2006) (13)
A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients (2015) (12)
Peritoneal Dialysis Prescription for Diabetic Patients (2005) (12)
The enigma of decreased creatinine generation in acute kidney injury. (2012) (12)
Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients (2014) (12)
Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients (2016) (11)
Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patients (2014) (11)
Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy. (2005) (11)
Why do physicians prescribe dialysis? A prospective questionnaire study (2017) (11)
Peroxisome Proliferator-Activated Receptor-γ Agonists Diminish Peritoneal Functional and Morphological Changes Induced by Bioincompatible Peritoneal Dialysis Solution (2006) (10)
Rate of Synthetic Oligosaccharide Degradation as a Novel Measure of Amylase Activity in Peritoneal Dialysis Patients (2008) (10)
High peritoneal residual volume decreases the efficiency of peritoneal dialysis. (1999) (10)
Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting. (2015) (10)
Chronic inflammation in PD patients. (2003) (10)
Bicarbonate-Based Peritoneal Dialysis Solution has Less Effect on Ingestive Behavior than Lactate-Based Peritoneal Dialysis Solution (2009) (10)
Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients (2019) (9)
Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study (2021) (9)
The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration – The Pan Thames Renal Audit (2010) (9)
Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality (2013) (8)
Determinants of N-Terminal Pro-Brain Natriuretic Peptide Variation in Hemodialysis Patients and Prediction of Survival (2014) (8)
Molecular genetics in renal medicine: what can we hope to achieve? (2002) (8)
The enigma of increasing serum leptin levels during peritoneal dialysis. (1999) (8)
The Effect of Icodextrin-Based Solutions on Peritoneal Transport in Rats Undergoing Chronic Peritoneal Dialysis (2001) (8)
Chapter 4 – Uremic Toxicity (2013) (8)
Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time (2017) (8)
Choice of dialysis modality among patients initiating dialysis: results of the Peridialysis study (2020) (8)
Mathematical Modeling of the Glucose-Insulin System During Peritoneal Dialysis With Glucose-Based Fluids (2011) (8)
Reply to A Molfino et al (2007) (7)
Nutritional Aspects of Adult Patients Treated With Chronic Peritoneal Dialysis Aspectos Nutricionais de Pacientes Adultos em Diálise Peritoneal (2006) (7)
Protein-Energy Malnutrition/Wasting During Peritoneal Dialysis (2009) (7)
Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5 (2020) (7)
Chapter 25 – Peritoneal Physiology (2005) (7)
Albumin-based solutions for peritoneal dialysis: investigations with a rat model. (1995) (7)
Peritoneal dialysis patient selection from a comorbidity perspective (2020) (7)
Intraperitoneal Addition of Hyaluronan Improves Peritoneal Dialysis Efficiency (1999) (7)
A novel bioactive haemodialysis system using dissolved dihydrogen (H 2 ) produced by water electrolysis: a clinical trial (2010) (7)
Statins to Treat Chronic Inflammation in Dialysis Patients — is this Feasible? (2007) (7)
Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study (2018) (7)
Vasodilatation by intraperitoneal addition of nitroprusside is not a model for high peritoneal transport. (1999) (7)
A genome-wide association study suggests correlations of common genetic variants with peritoneal solute transfer rates in patients with kidney failure receiving peritoneal dialysis. (2021) (6)
Lipid disorders, statins and the peritoneal membrane. (2009) (6)
How should we measure peritoneal dialysis adequacy in the clinic. (2009) (6)
Intraperitoneal atrial natriuretic peptide increases peritoneal fluid and solute removal. (2001) (6)
Cost-Effectiveness Analysis of Patiromer in Combination with Renin–Angiotensin–Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden (2020) (6)
Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins (2022) (5)
Peritoneal transport with icodextrin solution. (2006) (5)
Prevention and treatment of the malnutrition, inflammation and atherosclerosis (MIA) syndrome in uremic patients. (2000) (5)
Selection of Genetic and Phenotypic Features Associated with Inflammatory Status of Patients on Dialysis Using Relaxed Linear Separability Method (2014) (5)
A Simple and Fast Method to Estimate Peritoneal Membrane Transport Characteristics Using Dialysate Sodium Concentration (1999) (5)
New Strategies for Management of Malnutrition in Peritoneal Dialysis Patients (2000) (5)
Amphotericin B does not increase peritoneal fluid removal. (1998) (5)
Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy (2022) (5)
Dioctyl sodium sulphosuccinate increases net ultrafiltration in peritoneal dialysis. (1997) (5)
Sieving coefficients for small solutes during experimental peritoneal dialysis in rats. (1995) (5)
Sparing effect of peritoneal dialysis vs hemodialysis on BMD changes and its impact on mortality (2020) (5)
Malnutrition in Patients with End-Stage Renal Disease - Anorexia,Cachexia and Catabolism (2007) (5)
Fluid and Solute Transport using Different Sodium Concentrations in Peritoneal Dialysis Solutions (2001) (5)
Association of Longitudinal High-Sensitivity Troponin T With Mortality in Patients With Chronic Kidney Disease. (2022) (4)
Statins and lipid-lowering strategies in PD. (2012) (4)
High-sensitivity troponins in dialysis patients: variation and prognostic value (2020) (4)
European best practice guidelines for peritoneal dialysis. 1 General guidelines. (2005) (4)
Ultrafiltration Failure in Peritoneal Dialysis Patients (2004) (4)
Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients. (2007) (4)
Lipid disorders, statins and the peritoneal membrane. (2009) (4)
Influence of Erythropoiesis-Stimulating Agents on Glycated Hemoglobin in Nondiabetic Kidney Diseases at the Start of Dialysis (2010) (4)
FP411THE ASSOCIATION BETWEEN RENAL FUNCTION AND TROPONIN T OVER TIME IN STABLE CKD PATIENTS (2019) (3)
How should we measure peritoneal dialysis adequacy in the clinic. (2009) (3)
Non-thyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis? (2014) (3)
Dietary Requirements in Peritoneal Dialysis (1997) (3)
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study (2021) (3)
Peritoneal Physiology (2010) (3)
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study (2021) (3)
Epidemiology and outcome - 2 (2009) (3)
Cardiovascular complications - 3 (2009) (2)
Lipoprotein Lipase 1595 C/G and Hepatic Lipase –480 C/T Polymorphisms – Impact on Lipid Profile in Incident Dialysis Patients (2008) (2)
The 12th International Conference on Continuous Renal Replacement Therapies (CRRT). March 7–10, 2007, San Diego, Calif. (2007) (2)
MO058PREVENTION OF PERITONITIS IN PATIENTS WITH PERITONEAL DIALYSIS - EFFECTS OF REGULAR, TARGETED FOLLOW-UP OF PATIENTS´ THEORETICAL KNOWLEDGE AND PRACTICAL SKILLS WITH FOCUS ON INFECTION PROPHYLAXIS (PEPS) - A RANDOMIZED, CONTROLLED TRIAL (2017) (2)
Peritoneal transport and EPO (1994) (2)
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease (2021) (2)
First-year mortality in incident dialysis patients: results of the Peridialysis study (2021) (2)
Can plasma cystatin C level be used to estimate residual renal function in patients on dialysis? (2007) (2)
Nutrition and clinical outcome in peritoneal dialysis patients. (1999) (2)
Protein-energy wasting, inflammation and oxidative stress (2009) (1)
Introduction: BUFFER SYSTEMS AND BIOCOMPATIBILITY IN PERITONEAL DIALYSIS (2003) (1)
Chapter 26 – Peritoneal Physiology (2010) (1)
Acknowledgement to Referees (2006) (1)
Peritoneal fluid kinetics: comparison between polyglucose solution and albumin solution. (1999) (1)
Epidemiology and outcome research in CKD 5D (2012) (1)
[Choose the right method fo estimation of kidney function. The nature of the problem determines which method should be used]. (2009) (1)
Continuous Renal Replacement Therapies (1995) (1)
P300 MUSCLE ATROPHY, INFLAMMATION AND CLINICAL OUTCOME IN INCIDENT AND PREVALENT DIALYSIS PATIENTS (2008) (1)
MP666INFLAMMATION DOWN REGULATES CYTOCHROME P450 MEDINATED DRUG METABOLISM IN HEMODIALYSIS PATIENTS (2016) (1)
A new, safe and convenient 5-L dual-chamber container for automated peritoneal dialysis. (2011) (1)
Protein-energy wasting, inflammation and oxidative stress (2009) (1)
European guidelines on when to start dialysis: check the facts first before commenting. (2012) (1)
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients (2022) (1)
[Medical and human aspects interact in dignified withdrawal of dialysis treatment]. (1991) (1)
Peritoneal dialysis - clinical (2013) (1)
FP649CAUSES OF UNPLANNED DIALYSIS INITIATION: RESULTS OF THE NORDIC PERIDIALYSIS STUDY (2018) (1)
Low plasma insulin-like growth factor-1 associates with increased mortality in chronic kidney disease patients with reduced muscle strength. (2022) (1)
[Drug dosage should be based on renal function]. (2013) (1)
Inverse association of transferrin saturation with mortality risk in chronic kidney disease (2020) (1)
Do metabolic derangements in end‐stage polycystic kidney disease differ versus other primary kidney diseases? (2018) (1)
Nutritional management of chronic peritoneal dialysis patients (2022) (0)
[Unequal access to health care in the country: assisted peritoneal dialysis not offered to all who need it]. (2012) (0)
P0941HEALTHY K-RICH DIET IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS USING SODIUM ZIRCONIUM CYCLOSILICATE (SZC) TO CONTROL HYPERKALEMIA: A FEASIBILITY STUDY (HELPFUL) (2020) (0)
MO580: Healthy Plant-Based Diet for Patients With Chronic Kidney Disease (CKD) Through Use of Sodium Zirconium Cyclosilicate (SZC): A Feasibility Study (Helpful) (2022) (0)
Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients (2018) (0)
List of Contributors (2019) (0)
OP-NDTJ200001 1157..1162 (2020) (0)
Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy (2022) (0)
MO681: Association of Framingham Risk Score with Mortality in Kidney Failure Patients from China and Sweden (2022) (0)
P1131STEADY CONCENTRATION PERITONEAL DIALYSIS INCREASES ULTRAFILTRATION AND SODIUM REMOVAL COMPARED TO CAPD (2020) (0)
SP019IS END-STAGE POLYCYSTIC KIDNEY DISEASE ASSOCIATED WITH IMPAIRMENT OF GLUCOSE METABOLISM? (2016) (0)
Subject Index Vol. 26, 2008 (2008) (0)
FP392DYNAMIC PREDICTION OF MORTALITY IN ADVANCED CKD USING TROPONIN T (2019) (0)
Acknowledgement to Reviewers (2010) (0)
FP559ELEVATED CIRCULATING S100A12 ASSOCIATES WITH VASCULAR DISEASE AND CLINICAL OUTCOME IN PERITONEAL DIALYSIS PATIENTS (2015) (0)
SP242GLOMERULAR FILTRATION RATE ESTIMATION USING BETA TRACE PROTEIN: EXTERNAL VALIDATION OF THREE EQUATIONS (2016) (0)
MP528SKIN AUTOFLUORESCENCE (SAF), A MARKER OF TISSUE ADVANCED GLYCATED END-PRODUCTS (AGE), AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS (2016) (0)
Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation (2011) (0)
Testosterone deﬁciency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease (2012) (0)
FP336HIGHER NEUTROPHIL TO LYMPHOCYTE RATIO ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS (2018) (0)
[It is better use a modern formula than being formal]. (2013) (0)
Subject Index Vol. 24, 2006 (2006) (0)
CKD NUTRITION, INFLAMMATION AND OXIDATIVE STRESS (2014) (0)
MO445BRAIN AND GUT AXIS IN CHRONIC KIDNEY DISEASE: FOCUS ON SPECIFIC BIOMARKERS, AND TIGHT JUNCTION PROTEINS (2021) (0)
Treatment practices and outcomes in incident peritoneal dialysis patients: the Swedish Renal Registry 2006–2015 (2021) (0)
P0669HIGH ESTIMATED PHENOTYPIC AGE ASSOCIATES WITH WORSE CLINICAL OUTCOME IN CHRONIC KIDNEY DISEASE PATIENTS (2020) (0)
[Peritoneal dialysis-associated peritonitis caused by Rhizobium species - a case report]. (2022) (0)
Subject Index Vol. 29, 2009 (2009) (0)
PP111-MON SERUM ALBUMIN (S-ALB) AS PREDICTOR OF NUTRITIONAL STATUS AND MORTALITY IN END-STAGE RENAL DISEASE (ESRD) PATIENTS (PTS) (2011) (0)
Gene Expression Analysis in Inflamed and Non-inflamed Hemodialysis (HD) Patients Using a cDNA Microarray (2003) (0)
Jonas Bergström, MD, PHD (1929-2001): Scientist, Physician, Researcher, Mentor, Musician, and Friend (2001) (0)
The role of peritoneal dialysis in renal replacement therapy: an update on medical aspects. (2005) (0)
Paradoxes in Peritoneal Transport of Small Solutes (1996) (0)
How to Assess Peritoneal Transport: Which Test Should We Use? (2009) (0)
Cardiovascular complications of CKD 2 vi 311 Cardiovascular complications of CKD 2 SaP 234 (2007) (0)
How to assess peritoneal transport: which test should we use? (2009) (0)
Reply to ‘Depression and clinical outcomes in CKD: do anti-depressants play a role? (EQUAL Study)’ (2022) (0)
Peritoneal dialysis (2013) (0)
Book Review: Lymphatic and Non-Lymphatic Fluid Loss from the Peritoneal Cavity (1994) (0)
Blood pressure and kidney outcomes in patients with severely decreased glomerular filtration rate: a nationwide observational cohort study (2022) (0)
FC020BONE MINERAL DENSITY AT VARIOUS SITES VERSUS MORTALITY IN END-STAGE RENAL DISEASE (ESRD) (2019) (0)
Telomere shortening, a new mortality risk factor in dialysis patients. Associations with inflammatory markers and fetuin-a levels (2007) (0)
SP402PENTOSIDINE IN END-STAGE RENAL DISEASE PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) VERSUS OTHER ETIOLOGIES (2019) (0)
PP112-MON SELF-RATED APPETITE IS A POOR PREDICTOR OF MORTALITY IN PRE-DIALYSIS AND DIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) (2011) (0)
Education of ESRD patients on dialysis modality selection: 'intensive haemodialysis first': reply (2010) (0)
Plasma Lipoprotein(a) Is Related to Peritoneal Albumin Losses (1997) (0)
’ s response to reviews Title : Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients (2019) (0)
SP298HIGHER MEAN CORPUSCULAR VOLUME ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS (2018) (0)
[Dialysis is life-sustaining--but when to initiate it?]. (2002) (0)
MO035INFLAMMATION MODIFIES THE MORTALITY PREDICTIVE CAPACITY OF OXIDATIVE DNA DAMAGE IN CHRONIC KIDNEY DISEASE PATIENTS (2017) (0)
MP311 EFFECT OF INCREASED ULTRAFILTRATION ON B-TYPE NATRIURETIC PEPTIDE (BNP) AND C-REACTIVE PROTEIN (CRP): DOES HYPERVOLEMIA MEDIATES CARDIAC DYSFUNCTION AND INFLAMMATION IN HEMODIALYSIS (2005) (0)
Contents, Vol. 13, 1995 (1993) (0)
Contents Vol. 24, 2006 (2006) (0)
TO024COMBINATION OF GENOTYPE AND PHENOTYPE FEATURES AS PREDICTORS OF INFLAMMATION, CARDIOVASCULAR DISEASE AND PROTEIN ENERGY WASTING IN PATIENTS WITH CHRONIC KIDNEY DISEASES (2017) (0)
FO055EVALUATION OF PREDICTION MODELS FOR PROGRESSION OF CHRONIC KIDNEY DISEASE TO KIDNEY FAILURE: A COMPREHENSIVE EXTERNAL VALIDATION STUDY (2019) (0)
MP429SUBJECTIVE GLOBAL ASSESSMENT OF NUTRITIONAL STATUS AS PREDICTOR OF MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS (2017) (0)
Department of Clinical Sciences Interventions and Technology (CLINTEC) Karolinska Institutet, Stockholm, Sweden VASCULAR AND INFLAMMATORY MARKERS IN CHRONIC KIDNEY DISEASE (2015) (0)
MP440OBSTRUCTIVE AND RESTRICTIVE LUNG FUNCTION ASSOCIATES WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2017) (0)
No association between plasma total homocysteine and common carotid intima thickness in end-stage renal disease patients (2002) (0)
Factors associated with time to first dialysis-associated peritonitis episode: Data from the Peritonitis Prevention Study (PEPS). (2023) (0)
Outcome of atrial fibrillation among patients with end-stage renal disease (2010) (0)
SP286PLASMA BETA TRACE PROTEIN PREDICTS MORTALITY IN CKD: RELATION WITH ENDOTHELIAL DYSFUNCTION (2016) (0)
SO059CIRCULATING PROTEINS AS PREDICTORS OF CARDIOVASCULAR MORTALITY IN END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS - A PROTEOMIC APPROACH (2017) (0)
SP564HIGH SENSITIVE TROPONIN T AND TROPONIN I THREE MONTH VARIATION IN PREVALENT HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS (2015) (0)
Treatment of malnutrition and anaemia (2011) (0)
P1399SPARING EFFECT OF PERITONEAL DIALYSIS VS HEMODIALYSIS ON CHANGE OF BONE MINERAL DENSITY EVALUATED BY WHOLE-BODY DXA AFTER INITIATION OF DIALYSIS THERAPY AND ITS IMPACT ON CLINICAL OUTCOME (2020) (0)
P0714RELATIONSHIP BETWEEN BIOLOGICAL AGE ESTIMATED BY SKIN AUTOFLUORESCENCE, CHRONOLOGICAL AGE, AND MORTALITY IN CHRONIC KIDNEY DISEASE (2020) (0)
Nephrology in Sweden (2021) (0)
Protein-energy wasting, inflammation and oxidative stress in CKD 5D (2011) (0)
MP383LOW BONE MINERAL DENSITY OF LEGS AND FEMORAL NECK ASSOCIATES WITH CORONARY CALCIFICATION SCORE IN FEMALE END-STAGE RENALDISEASE PATIENTS (2016) (0)
MO445 BRAIN AND GUT AXIS IN CHRONIC KIDNEY DISEASE: FOCUS ON SPECIFIC BIOMARKERS, AND TIGHT JUNCTION PROTEINS (2021) (0)
Converting from face-to-face to postal follow-up and its effects on participant retention, response rates and errors: lessons from the EQUAL study in the UK (2021) (0)
Subject Index Vol. 13, 1995 (1995) (0)
Contents Vol. 29, 2009 (2009) (0)
24th Annual Meeting of the International Society of Blood Purification (ISBP). September 8–10, 2006, Nara, Japan (2006) (0)
Systemic inflammation in hemodialysis patients is associated with increased oxidation of the nucleotide pool as revealed by serum levels of 8oxo-dG (2005) (0)
SP356PULMONARY DYSFUNCTION IS LINKED TO MALNUTRITION AND INFLAMMATION IN CHRONIC KIDNEY DISEASE PATIENTS (2016) (0)
The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease (2023) (0)
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability (2010) (0)
SP323HIGH FIBRINOGEN LEVELS ARE INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) (2018) (0)
[Dialysis treatment is satisfactory. A survey of all patients with chronic renal failure in Stockholm]. (1995) (0)
Progression & risk factors CKD 1-5 (2) (2011) (0)
CKD BONE DISEASE (2014) (0)
MO673: Association of Mean Corpuscular Volume with Mortality in Kidney Failure Patients: Opposite Findings in Chinese and Swedish Kidney Failure Patients (2022) (0)
Special Problems in Caring for Patients on Peritoneal Dialysis (2016) (0)
Contents Vol. 26, 2008 (2008) (0)
Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients (2023) (0)
FC064RISK FACTORS FOR UNPLANNED DIALYSIS INITIATION: FINAL RESULTS OF THE NORDIC PERIDIALYSIS STUDY (2019) (0)
P1137FACTORS DETERMINING CHOICE OF DIALYSISI MODALITY AMONG PATIENTS INITIATING DIALYSIS. RESULTS OF THE PERIDIALYSIS STUDY (2020) (0)
Peritoneal Dialysis (2012) (0)
P0673INVERSE ASSOCIATION OF TRANSFERRIN SATURATION WITH MORTALITY RISK IN CHRONIC KIDNEY DISEASE (2020) (0)
MO708: Association of Atherogenic Index of Plasma (AIP) with Mortality in Chinese and Swedish End-Stage Kidney Disease Patients: Results from Two Cohorts (2022) (0)
FP580MUSCLE STRENGTH, MUSCLE MASS AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS (2015) (0)
P1160INCREASED REMOVAL RATES OF FLUID AND SODIUM DURING STEADY CONCENTRATION PERITONEAL DIALYSIS COMPARED TO ICODEXTRIN AND PERITONEAL EQUILIBRATION TEST (2020) (0)
Anaemia in CKD 5D (2011) (0)
Estimated hepatic and adipose tissue stearoyl-coa desaturase-1 activities are associated with inflammation and all-cause mortality in dialysis patients (2012) (0)
P1448FACTORS ASSOCIATED WITH INCREASED MORTALITY AFTER DIALYSIS INITIATION. RESULTS OF THE PERIDIALYSIS STUDY (2020) (0)
SP429CIRCULATING PLASMA PENTOSIDINE IN PRE-DIALYSIS, PRE-TRANSPLANT, PERITONEAL DIALYSIS (PD) AND HEMODIALYSIS (HD) PATIENTS (PTS) (2015) (0)
Chronic Kidney Disease: Need for an Integrated Therapy Against Malnutrition and Wasting (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Olof Heimbürger?

Olof Heimbürger is affiliated with the following schools:

Stockholm University
University of Oviedo
Uppsala University
Lund University
Karolinska Institute